Intent-Bound Surgical Procedure Execution

What This Application Specifies

Surgeon intent enters the architecture as a credentialed declaration: intended procedure (with CPT-coded scope), intended approach (open, laparoscopic, robot-assisted, hybrid), intended sub-phase boundaries (port placement, dissection, anastomosis, closure), intended escalation profile (when to halt for surgeon review, when to revert to manual control, when to summon a second-attending consultation). The intent admits through composite admissibility before authorizing procedure actuators — every motor command, every energy delivery, every staple firing references the active intent declaration as a precondition.

Intent authority composition structures map directly to surgical reality. Surgeon-of-record authority covers procedure intent and intraoperative decision-making. Hospital authority covers institutional intent: case-eligibility per credentialing committee review, equipment-status per biomedical engineering attestation, infection-control per OR turnover sign-off. Regulatory authority covers device-class intent: per-device FDA labeling, indications-for-use language, and the human-factors envelope established under AAMI HE75 use-error analysis. Anesthesia authority covers patient-physiology intent: hemodynamic targets, ventilation parameters, paralytic state. The architecture supports the multi-authority intent reality of surgical practice without collapsing it into a single permissions check.

Intent declarations themselves carry structure. A declared intent for a robotic-assisted prostatectomy includes the planned nerve-sparing approach, the predefined dissection planes, the energy modalities authorized for each tissue class, and the contingency escalation triggers (e.g., conversion to open if vascular control is lost). The declaration is signed by the surgeon-of-record, co-attested by the institutional credentialing record for that procedure, and bound to a specific patient-consent record. This binding is what subsequent admissibility checks reference.

Why It Matters Operationally

Current surgical-robotic autonomy faces a structural intent gap. Surgeons configure systems that operate semi-autonomously — suturing, knot-tying, predefined dissection sequences — but the relationship between surgeon intent and system behavior is implementation-dependent and largely opaque to post-hoc review. When an autonomous sub-phase produces an adverse event, reconstructing what the surgeon intended versus what the system did requires forensic effort across vendor logs, OR video, EHR notes, and witness recollection. The FDA's post-market surveillance machinery operates downstream of this reconstruction problem.

Intent-bound execution closes the gap structurally. The intent is declared before induction; admissibility evaluates each actuation against intent; execution proceeds within intent scope; deviations from intent fail admissibility structurally rather than being caught (or missed) by an alarm. Human-factors expectations established under AAMI HE75 — that automation should make the operator's intended action easier and the unintended action harder — are no longer aspirational properties of the user-interface design; they are properties of the admissibility surface itself.

The operational consequence is that root-cause analysis after an adverse event begins with a complete intent transcript. Did the surgeon declare nerve-sparing, and did the dissection actuator nonetheless violate the spared region? Did the intent transition from elective to emergent at the moment of vascular injury, and did subsequent actuations admit against the new intent? Did the institutional credential lapse during the case, and did the architecture continue to admit on the basis of the pre-induction credential? These questions are answered by reading the audit, not by reconstructing it.

How It Composes With the Domain

Each procedure actuation admits against the active surgeon intent. A robotic instrument advancing toward a tissue plane references the intended dissection map; a stapler firing references the intended anastomosis specification; an energy device activating references the intended modality and power envelope for the current sub-phase. Cross-modality observations — endoscopic video, force-feedback telemetry, intraoperative ultrasound, fluorescence imaging — admit against intent context, so that observation reconciliation occurs against the declared procedure rather than against an implicit baseline.

Stage-gated commitment proceeds within intent scope. The transition from dissection to anastomosis requires that intent for the prior stage be fulfilled (or explicitly waived under documented justification) before the next-stage actuators authorize. Post-phase assessment compares declared intent against measured outcome: the intended dissection plane against the achieved plane, the intended hemostasis against the observed bleeding, the intended margin against the pathology read.

Surgeon takeover gains structural support. When surgeon intent shifts mid-case — escalation to an alternative approach, halt-for-review, conversion to open — the architecture admits the intent transition as a credentialed event. Subsequent actuations admit against the new intent, with the prior intent retained as a transition predecessor. Audit reconstruction traverses intent transitions structurally, so a regulatory reviewer or a malpractice expert can replay the case as a sequence of intent states rather than a flat log of motor commands.

Anesthesia and perfusion integrate as co-authority participants. A hemodynamic crash that pushes patient state outside the anesthesia-declared envelope produces an admissibility event that gates the surgical actuator — the procedure pauses structurally, not because a surgeon noticed and reached for a stop button, but because the composite intent (surgical plus anesthetic) no longer admits. This is the architectural form of the closed-loop OR that human-factors literature has been describing aspirationally for two decades.

What This Enables

Surgical-robotic autonomy gains structurally-supported surgeon-of-record authority. The surgeon's legal and ethical accountability for the case is no longer in tension with the system's autonomous behavior; the autonomous behavior is bound to the surgeon's declared intent, and the surgeon-of-record relationship is preserved structurally rather than rhetorically. Patient-safety outcomes gain audit-grade intent reconstruction: every adverse event review, every M&M conference, every malpractice deposition begins with a deterministic record of what was intended, what was actuated, and where the two diverged.

Regulatory frameworks (FDA 21 CFR 820 quality systems, EU MDR clinical-evaluation requirements, ISO 14971 risk management) gain structurally-supported intent governance. Pre-market submissions can describe intended use as an admissibility specification that the device enforces, rather than as labeling text that the device merely accompanies. Post-market surveillance under FDA MDR (Medical Device Reporting) operates against intent-transcript data of known structure. Human-factors validation under AAMI HE75 and IEC 62366 evaluates the admissibility surface directly, rather than evaluating UI proxies for it.

The architecture also supports surgical evolution. As autonomous-surgical procedures mature beyond suturing and knot-tying into autonomous tissue dissection, autonomous vascular control, and autonomous anastomosis construction, the intent specification language extends to cover the new procedure classes. As new intent-formulation tools emerge — pre-operative planning derived from imaging, AI-suggested approach modifications, intraoperative re-planning under unexpected anatomy — the architecture admits the changes through declared specification rather than through firmware update. The substrate that today gates a Class II surgical stapler can, without architectural change, gate a Class III autonomous-anastomosis device tomorrow.

Boundary Conditions and Failure Modes

Intent-bound execution does not eliminate surgical risk; it relocates the failure surface. An incorrectly declared intent (wrong procedure, wrong side, wrong patient) admits actuations against an incorrect baseline, so the architecture leans heavily on the credential and consent bindings established before induction. The Universal Protocol time-out, the surgical-site marking, and the patient-identity verification are not replaced — they become the inputs that the intent declaration references and that admissibility checks against.

Latency is bounded by the admissibility surface. A robotic instrument cannot wait for a regulatory authority round-trip on every motor command, so authority decisions are pre-composed into a local admissibility cache that is invalidated on credential or intent transition. The cache structure is itself a declared specification, reviewable under the same regulatory framework as the device firmware.

Emergency override remains available and remains credentialed. A surgeon converting to open under exsanguination does not type a justification; the surgeon executes the conversion, and the architecture admits the emergency-intent transition under the surgeon-of-record credential, deferring justification capture to post-case review. The audit records the deferred justification as a structural event, not as a missing field.

Training and credentialing intersect the substrate at the credential layer rather than at the actuator layer. A surgeon credentialed for robot-assisted hysterectomy but not for robot-assisted prostatectomy can declare and execute the former and not the latter; the institutional credentialing committee's privileging decision is the structural ground for the admissibility, and a privileging change propagates as a credential transition rather than as a workflow update. Proctored cases, where a credentialed proctor co-attests the operating surgeon's actions during a credentialing pathway, are first-class composite-intent events: the proctor's co-attestation appears in the audit as a structural participant, not as a free-text note.

Device interoperability across vendors composes through the same substrate. An operating room that integrates a robotic platform from one vendor, a surgical-energy platform from a second, an imaging system from a third, and an anesthesia machine from a fourth no longer relies on point-to-point integrations or on the IHE profiles' best-effort interoperability. Each device participates as a credentialed observer and actuator, with its FDA clearance scope encoded as the admissibility profile under which its actuations are authorized. The Medical Device Plug-and-Play (MD PnP) initiative's longstanding goal of a safety-interlocked OR becomes implementable because the interlock is a property of the substrate, not of any single vendor's gateway.